Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study
Titel:
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study
Auteur:
Cortot, Alexis B. Audigier-Valette, Clarisse Molinier, Olivier Le Moulec, Sylvestre Barlesi, Fabrice Zalcman, Gérard Dumont, Patrick Pouessel, Damien Poulet, Claire Fontaine-Delaruelle, Clara Hiret, Sandrine Dixmier, Adrien Renault, Patrick-Aldo Becht, Catherine Raffy, Olivier Dayen, Charles Mazieres, Julien Pichon, Eric Langlais, Alexandra Morin, Franck Moro-Sibilot, Denis Besse, Benjamin